|
|
Angiotech Pharmaceuticals Inc - Comparative Business Analysis Snapshot
Business Description
Angiotech Pharmaceuticals Inc. The Group's principal activity is to discover, develop and market innovative technologies and medical products. It operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceutical Technologies segment develops products, out-licenses technologies and markets partnerships with major medical device, pharmaceutical or biomaterials companies. The Medical Product segment manufactures and markets a wide range of single use, specialty medical devices with products focused on general surgery, oncology and tumor biopsy, interventional radiology and vascular surgery, ophthalmology and aesthetic surgery.
Competitor Analysis
This analysis compares Angiotech Pharmaceuticals Inc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
